glp 1 cold feet As GLP-1 drugs continue to gain popularity for weight loss, a lesser-known side effect is drawing attention from podiatrists: "Ozempic ."https://www.wowktv.com/national-news/ozempic-feet -the-latest-side-effect-among-glp-1-users-doctors-warn GLP-1s for Weight Loss: What

"Oxidative stress: oxidants and antioxidants"

Xolair (omalizumab) Disease area(s): Immunology/respiratory Manufacturer(s): Roche/Novartis 2024 Sales (USD): $4.45 billion Why it sold so well: Roches asthma drug Xolair clocked in global sales of CHF 2.47 billion ($2.80 billion) in 2024, marking a 16% increase compared to the previous year

Essentially, GLP-1 medications work by slowing gastric emptying, meaning food stays in your stomach longer before moving through your digestive tract

Biol Psychiatry 2020;88:797808.ArticlePubMedPMC 75

Main causes are due to atrophic gastritis and lack of Intrinsic Factor (IF), a glycoprotein produced by the stomach that is required for the absorption of B12